Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$66.76 USD
+0.60 (0.91%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $66.77 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC4/25/24 |
---|---|
Current Quarter | 1.03 |
EPS Last Quarter | 1.72 |
Last EPS Surprise | -2.27% |
ABR | 2.24 |
Earnings ESP
|
-89.07% |
---|---|
Current Year | 6.55 |
Next Year | 7.32 |
EPS (TTM) | 6.72 |
P/E (F1) | 10.10 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.34B | 6.76B | 27.49B | 27.96B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 6.78B | 6.87B | 27.88B | 28.55B |
Low Estimate | 6.13B | 6.56B | 27.18B | 27.24B |
Year ago Sales | 6.35B | 6.60B | 27.12B | 27.49B |
Year over Year Growth Est. | -0.15% | 2.50% | 1.37% | 1.73% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.03 | 1.63 | 6.55 | 7.32 |
# of Estimates | 11 | 10 | 13 | 12 |
Most Recent Consensus | 1.38 | 1.54 | 6.86 | 7.22 |
High Estimate | 1.80 | 1.78 | 7.23 | 7.73 |
Low Estimate | -1.69 | 1.41 | 3.69 | 6.61 |
Year ago EPS | 1.37 | 1.34 | 6.72 | 6.55 |
Year over Year Growth Est. | -24.82% | 21.64% | -2.53% | 11.78% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 0 |
Up Last 60 Days | 1 | 0 | 2 | 0 |
Down Last 7 Days | 1 | 1 | 1 | 2 |
Down Last 30 Days | 2 | 3 | 2 | 4 |
Down Last 60 Days | 4 | 4 | 4 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.03 | 1.63 | 6.55 | 7.32 |
7 Days Ago | 1.30 | 1.64 | 6.80 | 7.38 |
30 Days Ago | 1.56 | 1.66 | 7.05 | 7.50 |
60 Days Ago | 1.59 | 1.68 | 7.09 | 7.52 |
90 Days Ago | 1.70 | 1.78 | 7.37 | 7.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.11 | 1.63 | 5.34 | 7.02 |
Zacks Consensus Estimate | 1.03 | 1.63 | 6.55 | 7.32 |
Earnings ESP | -89.07% | 0.11% | -18.44% | -4.06% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.72 | 2.29 | 1.34 | 1.37 | NA |
Estimate | 1.76 | 1.91 | 1.60 | 1.63 | NA |
Difference | -0.04 | 0.38 | -0.26 | -0.26 | -0.05 |
Surprise | -2.27% | 19.90% | -16.25% | -15.95% | -3.64% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more